TNF-alpha induced necroptosis inhibitors (Harvard University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTNF-alpha induced necroptosis inhibitors (Harvard University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsMyocardial IschemiaKidney DiseasesCraniocerebral Trauma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard University
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaKidney DiseasesCraniocerebral Trauma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A